Exclusive:
Hong Kong is not politicising any vaccine, says health chief
Send a link to a friend
[February 19, 2021]
HONG KONG (Reuters) -
Hong Kong's top health official said on Friday the government had not
politicised any coronavirus vaccine, as she sought to reassure residents
worried about China's Sinovac, due to be rolled out in the global
financial hub from next week.
|
Health Secretary Sophia Chan told Reuters that standards had not
been lowered to accept the Sinovac vaccine and there was no pressure
from Beijing to get it approved in the Chinese-ruled city.
"The government has not politicised any vaccine. In fact, we really
think that one should not politicise any of the vaccination process,
because really the COVID-19 vaccine is our hope," she said in an
interview at her office.
Hong Kong formally approved Sinovac for emergency use on Thursday
with the public rollout starting on Feb 26.
One million doses of the vaccine arrived from Beijing in the former
British colony on Friday afternoon.
Hong Kong's 7.5 million residents will be able to get vaccinated at
29 centres across the city with 5 offering Sinovac and 24 offering
Pfizer/Biontech vaccines, due to arrive before the end of February,
Chan said.
"If people have worries, then they can choose the vaccine of their
choice," she said.
Anti-mainland sentiment has risen in Hong Kong since 2019 when
protesters took to the streets to push back against what they see as
Beijing's growing attempts to tighten its grip over the territory.
A January survey by the University of Hong Kong found that fewer
than 30% of people questioned said they would accept the Sinovac
vaccine.
Hong Kong's government said in early February that it was exempting
Sinovac from publishing results of its third phase clinical trials
in medical journals due to the "urgency" for vaccination.
The Pfizer-BioNTech vaccine – the first approved by Hong Kong's
Health department - was required to have published results in a
medical journal before being examined by the government's advisory
panel.
[to top of second column] |
Fosun Pharma is the partner for distributing the
Pfizer-BioNTech vaccine in Hong Kong. Batches of
1 million doses of the vaccine would be sent
from Germany every month, while Sinovac would
also send batches on a near monthly basis, Chan
said.
"We are planning within 2021 that the vaccines
can be available to all the Hong Kong people,"
she said.
Hong Kong's vaccination programme has lagged
other developed cities and is far behind
mainland China, which started its vaccine
program in July last year. Hong Kong has a
separate approval process from the mainland for
vaccines.
Hong Kong has secured a total of 22.5 million
doses of COVID-19 vaccines from Pfizer, Sinovac
and AstraZeneca.
Chan said the AstraZeneca vaccine was due around
midyear but there had been no discussion as to
how many doses would be initially supplied.
Hong Kong has recorded around 10,800 cases since
last January and 197 deaths. The city eased some
coronavirus restrictions on Thursday, re-opening
sports facilities and extending dining hours to
10 p.m. from 6 p.m.
Chan said that the government was reviewing what
benefits and incentives people could get once
vacinated, with regards to traveling and a
shorter quarantine period.
Hong Kong requires compulsory 21-day hotel
quarantine for all arrivals apart from mainland
China.
(Reporting by Farah Master; Editing by Anne
Marie Roantree, John Stonestreet and Raju
Gopalakrishnan)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
|